What is HPLC purity?
HPLC purity is the percentage of a peptide sample that consists of the target compound, measured by integrating the area under each peak in a high-performance liquid chromatography chromatogram and dividing the target-peak area by the sum of all detected peak areas. The standard reporting convention quotes purity at the 214 nm peptide-bond wavelength, with industry-standard research-peptide thresholds at ≥98% or ≥99%.
What the research literature says
High-performance liquid chromatography (HPLC) is an analytical separation technique that resolves the components of a peptide sample by differential partitioning between the mobile phase and the column’s stationary phase. Reversed-phase HPLC (RP-HPLC) is the dominant mode for peptide-purity verification — the peptide and any sequence variants, deletion peptides, deamidation products, or process-related impurities elute at characteristic retention times set by their hydrophobicity.
UV-visible absorbance detection at 214 nm (the wavelength at which the peptide bond absorbs strongly) is the standard detector configuration for purity quantitation. The chromatogram shows each detected component as a peak; integration of peak area yields the relative abundance of each component. The standard purity calculation: target-peptide peak area divided by the sum of all peak areas in the integration window, expressed as a percentage.
The analytical-validation framework for HPLC purity methods is set out in ICH Q2(R1) and the USP <621> general chapter on chromatography. The USP <1086> general chapter on impurities in drug substances and drug products covers impurity identification, qualification, and reporting thresholds. For peptide-supply verification specifically, the chromatogram itself is included on the certificate of analysis so the buyer can verify the integration and inspect the impurity profile directly.
Why this matters in research context
The HPLC purity number is the headline quality metric on every research-peptide COA. The ≥99% versus ≥98% threshold is the most commonly varied parameter across vendors — higher purity reduces the impurity profile that downstream experiments might inadvertently characterise alongside the target compound. For research applications sensitive to impurity-driven effects (some signalling-pathway research, some receptor-binding studies), the ≥99% threshold is the operational standard. For applications less sensitive to trace impurities, ≥98% is broadly acceptable.
Related compounds
- HPLC purity verification (glossary entry) — analytical methodology
- Lab results page — per-batch COA access framework
Related research questions
- What does 99% purity mean for peptides?
- How do you read a peptide COA?
- What is mass spectrometry for peptide identity?
References
- ICH Q2(R1) — Validation of Analytical Procedures: Text and Methodology. International Council for Harmonisation.
- USP <621> Chromatography. General chapter defining system suitability and reporting for chromatographic methods. United States Pharmacopeia.
- USP <1086> Impurities in Drug Substances and Drug Products. Framework for impurity identification, qualification, and reporting thresholds. United States Pharmacopeia.
Research-questions pages describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. Every compound in the Ronin catalog is sold strictly for laboratory and research use only.